Non-motor symptoms in Parkinson's disease

Ariane Park, Mark Stacy, Ariane Park, Mark Stacy

Abstract

Parkinson's disease is a hypokinetic movement disorder with cardinal motor features of bradykinesia, resting tremor and rigidity. However, non-motor symptoms, such as cognitive, neuropsychiatric, sleep, autonomic and sensory disturbances are gaining increasing attention. These non-motor symptoms may be intrinsic to the disease pathology or may be results of treatment with dopaminergic agents. Given that most, if not all, patients with Parkinson's disease will experience non-motor symptoms, it is important to be sensitive to these phenomena, especially since some non-motor signs may precede motor impairment. Treatment may include interventions independent of traditional, dopaminergic anti-Parkinson therapy or may be tailored to increase or reduce dopamine responsiveness of the symptom.

References

    1. Int J Geriatr Psychiatry. 2004 Jan;19(1):1-8
    1. Neurology. 2006 Apr 11;66(7):996-1002
    1. Acta Neuropathol. 2008 Apr;115(4):437-44
    1. Neurology. 1996 Feb;46(2):388-93
    1. Arch Neurol. 2003 Dec;60(12):1745-8
    1. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1749-52
    1. CNS Spectr. 2008 Mar;13(3 Suppl 4):18-25
    1. Neurology. 2007 May 1;68(18):1455-9
    1. Clin Neuropharmacol. 2001 Jul-Aug;24(4):221-7
    1. Neurology. 2005 Nov 22;65(10):1654-6
    1. Brain. 1983 Jun;106 (Pt 2):257-70
    1. Am J Med. 1993 Jul;95(1):38-48
    1. Mov Disord. 2006 Dec;21(12):2078-81
    1. Neurogastroenterol Motil. 2005 Dec;17(6):821-6
    1. Eur J Neurol. 2008 Sep;15(9):953-9
    1. Drugs Aging. 2002;19(10):733-9
    1. Med Clin North Am. 1999 Mar;83(2):469-81, vii
    1. Neurology. 2005 Dec 27;65(12):1907-13
    1. Mov Disord. 2001 Nov;16(6):1176-7
    1. Arch Neurol. 2008 Oct;65(10):1337-40
    1. N Engl J Med. 2004 Dec 9;351(24):2509-18
    1. Br J Pharmacol. 2006 Feb;147 Suppl 2:S25-40
    1. Neurology. 2006 Sep 12;67(5):742-7
    1. Mov Disord. 2007 Jul 15;22(9):1239-44
    1. N Engl J Med. 1999 Mar 11;340(10):757-63
    1. Synapse. 2008 Feb;62(2):149-53
    1. Expert Opin Pharmacother. 2006 Apr;7(5):529-38
    1. Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
    1. Neuroscience. 2005;135(1):299-303
    1. N Engl J Med. 2004 Feb 19;350(8):786-99
    1. Am J Psychiatry. 1992 Apr;149(4):443-54
    1. JAMA. 1997 Apr 2;277(13):1046-51
    1. Neurology. 2007 Apr 24;68(17):1356-63
    1. Sleep Med. 2007 Jan;8(1):60-4
    1. J Clin Rheumatol. 2008 Aug;14(4):253-4
    1. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9
    1. Neurology. 2007 Dec 4;69(23):2162-9
    1. Curr Med Res Opin. 2005 Jan;21(1):71-80
    1. Neurology. 2000 Sep 26;55(6):789-94
    1. Eur Neuropsychopharmacol. 2007 Feb;17(3):165-71
    1. Mov Disord. 2008 Jun 15;23(8):1065-75
    1. Mov Disord. 2006 Apr;21(4):456-61
    1. Brain. 2005 Jun;128(Pt 6):1314-22
    1. Biol Psychiatry. 2002 Sep 1;52(5):438-45
    1. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):708-12
    1. Neurology. 2001 Mar 27;56(6):730-6
    1. Neurology. 1998 Feb;50(2):515-7
    1. J Neural Transm Suppl. 2006;(70):477-84
    1. Arch Neurol. 2002 Aug;59(8):1249-52
    1. J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):371-4
    1. Mov Disord. 2003 Mar;18(3):287-93
    1. Mov Disord. 2008 Jan;23(1):35-41
    1. Ann Neurol. 1993 Nov;34(5):710-4
    1. World J Gastroenterol. 2008 Sep 7;14(33):5226-7
    1. Mov Disord. 2008 Jul 30;23(10):1361-9
    1. Neurology. 2003 Jun 10;60(11):1756-61
    1. Mov Disord. 2007 Oct 31;22(14):2037-42
    1. Mov Disord. 2007 Feb 15;22(3):313-8

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する